No Data
OpenAI has raised 6.6 billion dollars.
OpenAI has reportedly secured $6.6 billion (approximately 960 billion yen) in its latest funding round. The company's valuation is estimated at $157 billion. It is reported that the company's efforts to build world-class technology in the field of artificial intelligence (AI) will be further strengthened.
SoftBank Group to invest 0.5 billion dollars in OpenAI.
softbank group co's Vision Fund is reportedly planning to invest 0.5 billion dollars (71.5 billion yen) in OpenAI, according to sources familiar with the matter. It is reported to be part of OpenAI's planned fundraising. Fujitsu <6702>, TDSE <7046>, Headwaters <4011>, PKSHA Technology <3993>, Mitsui & Co. <8031>
OpenAI, with a valuation of over 100 billion dollars?
OpenAI, the American AI company, is reportedly in negotiations to raise several billion dollars in a new funding round. It is estimated that the company could be valued at over 100 billion dollars (approximately 14.5 trillion yen) in this round. If realized, it would be the largest inflow of external funds for OpenAI since receiving approximately 10 billion dollars in investment from Microsoft in January 2023. <6702> Fujitsu <7046>
Nvidia is in talks to raise funds for OpenAI.
Nvidia has been reported to have held discussions regarding its participation in the funding round of OpenAI, a US-based organization. It has also been reported that Apple and Microsoft are discussing their participation in this round, and the top three technology companies in terms of market capitalization will support OpenAI. <6702> Fujitsu, <7046> TDSE, <4011> Headwaters, <3993>
CYBERDYNE [List of Emerging Market Ratings]
Nomura (7779) Cyberdyne BUY position. Ratings for each company mentioned above are valid as of 08/19, according to our company's confirmation.
Dentsu Group revised downwards to 107.1 billion yen in operating profit, from 135.4 billion yen on 24 December.
Dentsu Group (4324) announced a revision of its financial estimates for the fiscal year ending in December 2024, lowering its operating profit from 135.4 billion yen to 107.1 billion yen due to anticipated revenue deficits in Asia-Pacific regions such as China and Australia, resulting in impairment losses. Additionally, expenses related to the sale of its business in Russia, against the background of the Ukrainian invasion, have exceeded expectations. Plus evaluation: Skylark (3197), Medpeer (6095), Yonshan Holdings (3962).
No Data
No Data